Literature DB >> 35182184

The study of laryngopharyngeal reflux needs adequate animal model.

Jerome R Lechien1,2,3, Christian Calvo-Henriquez4,5, Miguel Mayo-Yanez4,6, Mariam El Ayoubi7, Luigi A Vaira8, Antonino Maniacci4,9.   

Abstract

Entities:  

Keywords:  Animal; Head neck surgery; Laryngology; Laryngopharyngeal; Model; Otolaryngology; Reflux; Study

Mesh：

Year:  2022        PMID： 35182184     DOI： 10.1007/s00405-022-07314-w

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  10 in total

1.  Gastroesophageal reflux in laryngopharyngeal reflux patients: Clinical features and therapeutic response.

Authors:  Jerome R Lechien; Francois Bobin; Vinciane Muls; Pierre Eisendrath; Mihaela Horoi; Marie-Paule Thill; Didier Dequanter; Jean-Pierre Durdurez; Alexandra Rodriguez; Sven Saussez
Journal:  Laryngoscope       Date:  2019-12-26       Impact factor: 3.325

2.  Hypopharyngeal-Esophageal Impedance-pH Monitoring Profiles of Laryngopharyngeal Reflux Patients.

Authors:  Jerome R Lechien; Francois Bobin; Giovanni Dapri; Pierre Eisendrath; Charelle Salem; Francois Mouawad; Mihaela Horoi; Marie-Paule Thill; Didier Dequanter; Alexandra Rodriguez; Vinciane Muls; Sven Saussez
Journal:  Laryngoscope       Date:  2020-05-21       Impact factor: 3.325

3.  Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications.

Authors:  Clarence T Sasaki; Sotirios G Doukas; Jose Costa; Dimitra P Vageli
Journal:  Cancer       Date:  2019-07-16       Impact factor: 6.860

Review 4.  The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury.

Authors:  J A Koufman
Journal:  Laryngoscope       Date:  1991-04       Impact factor: 3.325

Review 5.  Animal Models of Barrett's Esophagus and Esophageal Adenocarcinoma-Past, Present, and Future.

Authors:  Harit Kapoor; Kush Raj Lohani; Tommy H Lee; Devendra K Agrawal; Sumeet K Mittal
Journal:  Clin Transl Sci       Date:  2015-07-27       Impact factor: 4.689

6.  Saliva Pepsin Concentration of Laryngopharyngeal Reflux Patients Is Influenced by Meals Consumed Before the Samples.

Authors:  Alexandra Rodriguez; Sven Saussez; Jerome R Lechien; Francois Bobin; Vinciane Muls; Mihaela Horoi; Marie-Paule Thill; Didier Dequanter; Camille Finck
Journal:  Laryngoscope       Date:  2020-06-08       Impact factor: 3.325

7.  The role of Glut-1 and H+/K+-ATPase expression in hyperplasia of mice laryngeal epithelium induced by pepsin.

Authors:  Yin-Jie Ao; Ting-Ting Wu; Zai-Zai Cao; Shui-Hong Zhou; Yang-Yang Bao; Li-Fang Shen
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-27       Impact factor: 3.236

Review 8.  Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets.

Authors:  Yading Li; Gaofan Xu; Bingduo Zhou; Yishuang Tang; Xiaowen Liu; Yue Wu; Yi Wang; Jing Kong; Tingting Xu; Cong He; Shengliang Zhu; Xiaosu Wang; Jianning Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-12-03       Impact factor: 3.236

9.  Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study.

Authors:  R Stephen McCain; Damian T McManus; Stephen McQuaid; Jacqueline A James; Manuel Salto-Tellez; Nathan B Reid; Stephanie Craig; Chintapuza Chisambo; Victoria Bingham; Eamon McCarron; Eileen Parkes; Richard C Turkington; Helen G Coleman
Journal:  Cancer Causes Control       Date:  2019-11-30       Impact factor: 2.506

10.  Impact of bile acids on the severity of laryngo-pharyngeal reflux.

Authors:  Eugenio De Corso; Silvia Baroni; Giampiero Salonna; Michele Marchese; Marilena Graziadio; GIovanni Di Cintio; Gaetano Paludetti; Guido Costamagna; Jacopo Galli
Journal:  Clin Otolaryngol       Date:  2020-09-17       Impact factor: 2.597
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.